GMO, an investment management company, released its year-end letter for 2025. As a market-neutral strategy that seeks to exploit the significant disparity between the valuations of value and growth stocks, the strategy is satisfied with its long-term performance. The Strategy returned 15.8% gross (13.4% net) for 2025. Since its inception, it has achieved a cumulative gross return of 69.3% (50.6% net), without any substantial reduction in the valuation gap. This was fueled by strong stock selection efforts, supported by a proprietary valuation model, along with robust risk management...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.